SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-17-018990
Filing Date
2017-03-24
Accepted
2017-03-24 07:30:32
Documents
1
Group Members
ABBOTT INVESTMENTS LUZXEMBOURG S.A.R.L.ABBOTT PRODUCTS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a17-9815_1sc13da.htm SC 13D/A 77255
  Complete submission text file 0001104659-17-018990.txt   78929
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Subject) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88753 | Film No.: 17711178
SIC: 2834 Pharmaceutical Preparations